The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission

Eur J Endocrinol. 2010 Jun;162(6):1035-42. doi: 10.1530/EJE-10-0007. Epub 2010 Mar 31.

Abstract

Background: The GH/insulin-like growth factor 1 axis is physiologically involved in the regulation of electrolytes and water homeostasis by kidneys, and influences glomerular filtration and tubular re-absorption processes. The aim of the study was to investigate renal structure and function in acromegalic patients during active disease and disease remission.

Patients: Thirty acromegalic patients (15 males and 15 females), aged 32-70 years, were enrolled for the study. Ten de novo patients had active disease, whereas 20 patients showed disease remission 1 year after medical treatment with somatostatin analogs (SA) (ten patients) or surgery (ten patients). Thirty healthy subjects matched for age, gender, and body surface area were enrolled as controls.

Results: In both active (A) and controlled (C) patients, creatinine clearance (P<0.001) and citrate (P<0.05) and oxalate levels (P<0.001) were higher, whereas filtered Na (P<0.001) and K (P<0.001) fractional excretions were lower than those in the controls. Urinary Ca (P<0.001) and Ph (P<0.05) levels were significantly increased compared with the controls, and in patients with disease control, urinary Ca (P<0.001) levels were significantly reduced compared with active patients. Microalbuminuria was significantly increased in active patients (P<0.05) compared with controlled patients and healthy control subjects. The longitudinal (P<0.05) and transverse (P<0.05) diameters of kidneys were significantly higher than those in the controls. In all patients, the prevalence of micronephrolithiasis was higher than that in the controls (P<0.001), and was significantly correlated to disease duration (r=0.871, P<0.001) and hydroxyproline values (r=0.639, P<0.001).

Conclusions: The results of the current study demonstrated that acromegaly affects both renal structure and function. The observed changes are not completely reversible after disease remission.

MeSH terms

  • Acromegaly / drug therapy
  • Acromegaly / metabolism
  • Acromegaly / pathology*
  • Acromegaly / physiopathology*
  • Adult
  • Aged
  • Citric Acid / metabolism
  • Creatinine / metabolism
  • Cross-Sectional Studies
  • Female
  • Humans
  • Kidney / metabolism
  • Kidney / pathology*
  • Kidney / physiopathology*
  • Male
  • Middle Aged
  • Remission Induction
  • Somatostatin / analogs & derivatives
  • Somatostatin / therapeutic use

Substances

  • Citric Acid
  • Somatostatin
  • Creatinine